Vitamin E is obtained only through the diet and has a number of important biological activities, including functioning as an antioxidant. Evidence that free radicals may contribute to pathological processes such as bronchopulmonary dysplasia (BPD), a disease of prematurity associated with increased lung injury, inflammation and oxidative stress, led to trials of the antioxidant vitamin E (α-tocopherol) to prevent BPD with variable results. These trials were all conducted at supraphysiologic doses and 2 of these trials utilized a formulation containing a potentially harmful excipient. Since 1991, when the last of these trials was conducted, both neonatal management strategies for minimizing oxygen and ventilator-related lung injury and our understanding of vitamin E isoforms in respiratory health have advanced substantially. It is now known that there are differences between the effects of vitamin E isoforms α-tocopherol and γ-tocopherol on the development of respiratory morbidity and inflammation. What is not known is whether improvements in physiologic concentrations of individual or combinations of vitamin E isoforms during pregnancy or following preterm birth might prevent or reduce BPD development. The answers to these questions require adequately powered studies targeting pregnant women at risk of preterm birth or their premature infants immediately following birth, especially in certain subgroups that are at increased risk of vitamin E deficiency (e.g., smokers). The objective of this review is to compile, update, and interpret what is known about vitamin E isoforms and BPD since these first studies were conducted, and suggest future research directions.

Keywords:
Bronchopulmonary dysplasia, Chronic lung disease of prematurity, Vitamin E, α-Tocopherol, γ-Tocopherol, Tocopherol, Oxidative stress
1.
Aschner J, Patrick S, Stark A, Lee S: The Scope and Organization of Neonatology: North American and Global Comparisons; in MacDonald MG, Seshia MMK (eds): Avery’s Neonatology: Pathophysiology and Management of the Newborn, ed 7. Philadelphia, LWW, 2015.
2.
Perrone S, Tataranno M, Buonocore G: Oxidative stress and bronchopulmonary dysplasia. J Clin Neonatol 2012; 1: 109–114.
3.
McEvoy C, Jain L, Schmidt B, Abman S, Bancalari E, Aschner J: Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc 2014; 11:S146–S153.
4.
Pryhuber G, Maitre N, Ballard R, Cifelli D, Davis S, Ellenberg J, Greenberg J, Kemp J, Mariani T, Panitch H, Ren C, Shaw P, Taus sig L, Hamvas A: Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States. BMC Pediatr 2015; 15: 37.
5.
Higgins R, Jobe A, Koso-Thomas M, Bancalari E, Viscardi R, Hartert T, Ryan R, Kallapur S, Steinhorn R, Konduri G, Davis S, Thebaud B, Clyman R, Collaco J, Martin C, Woods J, Finer N, Raju T: Executive summary of the workshop on bronchopulmonary dysplasia. J Pediatr 2018, in press.
6.
Bancalari E, del Moral T: Bronchopulmonary dysplasia and surfactant. Biol Neonate 2001; 80: 7–13.
7.
Campbell K: Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust 1951; 2: 48–50.
8.
Carlo W, Finer N, Walsh M, Rich W, Gantz M, Laptook A, Yoder B, Faix R, Das A, Poole W, Schibler K, Newman N, Ambalavanan N, Frantz I, Piazza A, Sánchez P, Morris B, Laroia N, Phelps D, Poindexter B, Cotten C, van Meurs K, Duara S, Narendran V, Sood B, O’Shea T, Bell E, Ehrenkranz R, Watterberg K, Higgins R: Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362: 1959–1969.
9.
Stevens T, Blennow M, Myers E, Soll R: Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; 4:CD14003063.
10.
Wheeler K, Klingenberg C, McCallion N, Morley C, Davis P: Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev 2010; 11: CD14003666.
11.
Shalish W, Sant’Anna G, Natarajan G, Sanjay C: When and how to extubate premature infants from mechanical ventilation. Curr Pediatr Rep 2014; 2: 18–25.
12.
Auten R, Davis J: Oxygen toxicity and reactive oxygen species: the devil is in the details. Nature 2009; 66: 121–127.
13.
Guy L, Lanman J, Dancis J: The possibility of total elimination of retrolental fibroplasia by oxygen restriction. Pediatrics 1956; 17: 247–249.
14.
Welty SE: Is there a role for antioxidant therapy in bronchopulmonary dysplasia? J Nutr 2001; 131: 947S-950S.
15.
Northway WJ, Rosan R, Porter D: Pulmonary disease following respiratory therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357–368.
16.
Jobe A, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.
17.
Rojas M, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605–610.
18.
Balinotti J, Tiller C, Llapur C, Jones M, Kimmel R, Coates C, Katz B, Nguyen J, Tepper R: Growth of the lung parenchyma early in life. Am J Respir Crit Care Med 2009; 179: 134–137.
19.
Jobe A: The new bronchopulmonary dysplasia. Curr Opin Pediatr 2011; 23: 167–172.
20.
Betteridge D: What is oxidative stress? Metabolism 2000; 49: 3–8.
21.
Papa S, Skulachev V: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997; 174: 305–319.
22.
Lambeth J: Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 2007; 43: 332–347.
23.
Fleury CH, Mignote B, Vayssiere J: Mitochondrial reactive oxygen species in cell death signaling. Biochemie 2002; 84: 131–141.
24.
van der Vliet A: NADPH oxidases in lung biology and pathology: host defense enzymes and more. Free Radic Biol Med 2008; 44: 938–955.
25.
Gerber C, Bruchelk G, Stegmann H, Schweins-berg F, CP S: Presence of bleomycin-detectable free iron in the alveolar system of preterm infants. Biochem Biophys Res Commun 1999; 257: 218–222.
26.
Nycyk J, Drury J, Cooke R: Breath pentane as a marker for lipid peroxidation and adverse outcomes in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 79:F67–F69.
27.
Ogihara T, Hirano K, Morinobu T, Kim H, Hiroi M, Ogihara H, Tamai H: Raised concentration of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999; 80:F21–F25.
28.
Ogihara T, Okamoto R, Kim H, Nagai A, Morinobu T, Moji H, Kamegai H, Hirano K, Ogihara H, Tamai H, Mino M: New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996; 39: 117–119.
29.
Han R, Stewart D: Defective lung vascular development in endothelial nitric oxide synthase deficient mice. Trends Cardiovasc Med 2006; 16: 29–34.
30.
Afshar S, Gibson L, Yuhanna I, Sherman T, Kerecman J, Grubb P, Yoder B, McCurnin D, Shaul P: Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2003; 284:L749–L758.
31.
Miller D, Turner S, Spiteri-Cornish D, Scaife A, Danielian P, Devereux G, Walsh G: Maternal vitamin D and E intakes during early pregnancy are associated with airway epithelial cell responses in neonates. Clin Exp Allergy 2015; 45: 920–927.
32.
Institute of Medicine: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, National Academies Press, 2000, pp 186–283.
33.
Cook-Mills JM, Abdala-Valencia H, Hartert T: Two faces of vitamin E in the lung. Am J Respir Crit Care Med 2013; 188: 279–284.
34.
Jiang Q, Christen S, Shigenaga M, Ames B: Gamma-tocopherol, the major form of vitamin E in the US, deserves more attention. Am J Clin Nutr 2001; 74: 714–722.
35.
Jiang Q: Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 2014; 72: 76–90.
36.
Sontag T, Parker R: Cytochrome P450 ω-hydroxylase pathway of tocopherol catabolism. Biol Chem 2002; 277: 25290–25296.
37.
Leonard S, Patterson E, Atkinson J, Ramakrishnan R, Cross C, Traber M: Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production. Free Radic Biol Med 2005; 38: 856–866.
38.
Herrera E, Barbas C: Vitamin E: action, metabolism and perspectives. J Physiol Biochem 2001; 57: 43–56.
39.
Horwitt M, Harvey C, Dahm C Jr, Searcy M: Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972; 203: 223–236.
40.
Rochow N, Moller S, Fusch G, Drogies T, Fusch C: Levels of lipids in preterm infants fed breast milk. Clin Nutr 2010; 29: 94–99.
41.
Thurnham D, Davies J, Crump B, Situnayake R, Davis M: The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986; 23: 514–520.
42.
Reiter E, Jiang Q, Christen S: Anti-inflammatory properties of α- and γ-tocopherol. Mol Aspects Med 2007; 28: 668–691.
43.
Burbank A, Duran C, Almond M, Wells H, Jenkins S, Jiang Q, Yang C, Wang T, Zhou H, Hernandez M, Peden D: A short course of gamma-tocopherol mitigates LPS-induced inflammatory responses in humans ex vivo. J Allergy Clin Immunol 2017; 140: 1179–1181.
44.
Burbank A, Duran C, Pan Y, Burns P, Jones S, Jiang Q, Yang C, Jenkins S, Wells H, Alexis N, Kesimer M, Bennett W, Zhou H, Peden D, Hernandez M: Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma. J Allergy Clin Immunol 2017, Epub ahead of print.
45.
Eldridge M, Peden D: Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2000; 105: 475–481.
46.
Hernandez M, Wagner J, Kala A, Mills K, Wells H, Alexis N, Lay J, Jiang Q, Zhang H, Zhou H, Peden D: Vitamin E, γ-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers. Free Radic Biol Med 2013; 60: 56–62.
47.
Mills K, Lay J, Wu W, Robinette C, Kesic M, Dreskin S, Peden D, Hernandez M: Vitamin E, γ-tocopherol, diminishes ex vivo basophil response to dust mite allergen. Allergy 2014; 69: 541–544.
48.
Wagner J, Harkema J, Jiang Q, Illek B, Ames B, Peden D: γ-Tocopherol attenuates ozone-induced exacerbation of allergic rhinosinusitis in rats. Toxicol Pathol 2009; 37: 481–491.
49.
Wagner J, Jiang Q, Harkema J, Ames B, Illek B, Roubey R, Peden D: γ-Tocopherol prevents airway eosinophilia and mucous cell hyperplasia in experimentally induced allergic rhinitis and asthma. Clin Exp Allergy 2008; 38: 501–511.
50.
Wagner J, Jiang Q, Harkema J, Illek B, Patel D, Ames B, Peden D: Ozone enhancement of lower airway allergic inflammation is prevented by γ-tocopherol. Free Radic Biol Med 2007; 43: 1176–1188.
51.
Wiser J, Alexis N, Jiang Q, Wu W, Robinette C, Roubey R, Peden D: In vivo γ-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects. Free Radic Biol Med 2008; 45: 40–49.
52.
Berdnikovs S, Abdala-Valencia H, McCary C, Somand M, Cole R, Garcia A, Bryce P, Cook-Mills J: Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment. J Immunol 2009; 182: 4395–4405.
53.
McCary C, Abdala-Valencia H, Berdnikovs S, Cook-Mills JM: Supplemental and highly elevated tocopherol doses differentially regulate allergic inflammation: reversibility of α-tocopherol and γ-tocopherol’s effects. J Immunol 2011; 186: 3674–3685.
54.
Marchese M, Kumar R, Colangelo L, Avila P, Jacobs D, Gross M, Sood A, Liu K, Cook-Mills J: The vitamin E isoforms α-tocopherol and γ-tocopherol have opposite associations with spirometric parameters: the CARDIA study. Respir Res 2014; 15: 31.
55.
Yoshikawa S, Morinobu T, Hamamura K, Hirahara F, Iwamoto T, Tamai H: The effect of γ-tocopherol administration on α-tocopherol levels and metabolism in humans. Eur J Clin Nutr 2005; 59: 900–905.
56.
Larkin E, Gao Y, Gebretsadik T, Hartman T, Wu P, Wen W, Yang G, Bai C, Jin M, Roberts L, Gross M, Shu X, Hartert T: New risk factors for adult-onset incident asthma: a nested case-control study of host antioxidant defense. Am J Respir Crit Care Med 2015; 191: 45–53.
57.
Turner SW, Campbell D, Smith N, Craig LCA, McNeill G, Forbes SH, Harbour PJ, Seaton A, Helms PJ, Devereux GS: Associations between fetal size, maternal α-tocopherol and childhood asthma. Thorax 2010; 65: 391–397.
58.
Islam S, Narra V, Cote GM, Manganaro TF, Donahoe PK, Schnitzer JJ: Prenatal vitamin E treatment improves lung growth in fetal rats with congenital diaphragmatic hernia. J Pediatr Surg 1999; 34: 172–176.
59.
Peroni DG, Bonomo B, Casarotto S, Boner AL, Piacentini GL: How changes in nutrition have influenced the development of allergic diseases in childhood. Ital J Pediatr 2012; 38: 22.
60.
Falciglia HS, Johnson JR, Sullivan J, Hall CF, Miller JD: Complex antioxidant relationships and derangements in premature infants with respiratory-distress syndrome and bronchopulmonary dysplasia. Pediatr Res 1994; 35: A51–A51.
61.
Falciglia HS, Johnson JR, Sullivan JA, Hall CF, Miller JD, Riechmann GC, Falciglia GA: Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am J Perinatol 2003; 20: 97–107.
62.
Falciglia H, Ginn-Pease M, Falciglia G, Lubin A, Frank D, Chang W: Vitamin E and selenium levels of premature infants with severe respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr Perinat Nutr 1988; 2: 35–49.
63.
Haga P, Ek J, Kran S: Plasma tocopherol levels and vitamin E/β-lipoprotein relationships during pregnancy and in cord blood. Am J Clin Nutr 1982; 36: 1200–1204.
64.
Hoppu U, Salo-Vaananen P, Lampi A-M, Isolauri E: Serum alpha- and gamma-tocopherol levels in atopic mothers and their infants are correlated. Biol Neonate 2005; 88: 24–26.
65.
Wu S, Chou Y: Measurement of serum vitamin E isomers in fullterm and preterm infants. Chang Gung Med J 2001; 24: 793–798.
66.
Didenco S, Gillingham M, Go M, Leonard S, Traber M, McEvoy C: Increased vitamin E intake is associated with higher α-tocopherol concentration in the maternal circulation but higher α-carboxyethyl hydroxychroman concentration in the fetal circulation. Am J Clin Nutr 2011; 93: 368–373.
67.
Romeu-Nadal M, Morera-Pons S, Castellote AI, Lopez-Sabater MC: Determination of γ- and α-tocopherols in human milk by a direct high-performance liquid chromatographic method with UV-vis detection and comparison with evaporative light scattering detection. J Chromatogr A 2006; 1114: 132–137.
68.
Lima M, Dimenstein R, Ribeiro K: Vitamin E concentration in human milk and associated factors: a literature review. J Pediatr 2014; 90: 440–448.
69.
Elisia I, Kitts D: Differences in vitamin E and C profile between infant formula and human milk and relative susceptibility to lipid oxidation. Int J Vitam Nutr Res 2013; 83: 311–319.
70.
Ehrenkranz R, Bonta B, RC A, Warshaw J: Amelioration of bronchopulmonary dysplasia after vitamin E administration – a preliminary report. N Engl J Med 1978; 299: 564–569.
71.
Ehrenkranz RA, Ablow R, Warshaw J: Prevention of bronchopulmonary dysplasia with vitamin E administration during the acute stages of respiratory distress syndrome. J Pediatr 1979; 95: 873–878.
72.
Behrman R, Saldanha RL, Cepeda EE, Poland RL: The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 1982; 101: 89–93.
73.
Watts JL, Milner R, Zipursky A, Paes B, Ling E, Gill G, Fletcher B, Rand C: Failure of supplementation with vitamin-E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Respir J 1991; 4: 188–190.
74.
Milner R, Watts J, Paes B, Zipursky A: RLF in < 1,500 Gram Neonates. Part of a Randomized Clinical Trial of the Effectiveness of Vitamin E: Retinopathy of Prematurity Conference. Columbus, Ross Laboratories, 1981, pp 703–716.
75.
Hittner H, Godio L, Rudolph A, Adams J, Garcia-Prats J, Friedman Z, Kautz J, Monaco W: Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981; 305: 1365–1371.
76.
Speer M, Bilfeld C, Rudolph A, Chadda P, Holbein M, Hittner H: Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: evidence for efficacy of early intramuscular vitamin E administration. Pediatrics 1984; 74: 1107–1112.
77.
Johnson L, Quinn G, Abbasi S, Otis C, Goldstein D, Sacks L, Porat R, Fong E, Delivoria-Papadopoulos M, Peckham G, Schaffer D, Bowen JF: Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr 1989; 114: 827–838.
78.
Brion L, Bell E, Raghuveer T: Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003; 4:CD003665.
79.
Kiss L, Walter F, Bocsik A, Veszelka S, Ozsvari B, Puskas L, Szabo-Revesz P, Deli M: Kinetic analysis of the toxicity of pharmaceutical excipients cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci 2013; 102: 1173–1181.
80.
Campos F, Victorino V, Martins-Pinge M, Cecchini A, Panis C, Cecchini R: Systemic toxicity induced by paclitaxel in vivo is associated with the solvent cremophor EL through oxidative stress-driven mechanisms. Food Chem Toxicol 2014; 68: 78–86.
81.
Finer N, Peters K, Hayek Z, Merkel C: Vitamin E and necrotizing enterocolitis. Pediatrics 1984; 73: 387–393.
82.
Fischer WC, Whanger PD: Effects of selenium deficiency on vitamin-E metabolism in rats. J Nutr Sci Vitaminol 1977; 23: 273–280.
83.
Berger TM, Frei B, Rifai N, Avery ME, Suh J, Yoder BA, Coalson JJ: Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 1998; 43: 719–726.
84.
Vento M, Moro M, Escrig M, Arruza L, Villar G, Izquierdo I, Roberts L, Arduini A, Escobar J, Sastre J, Asensi M: Preterm resuscitation with low oxygen causes less oxidative stress, inflammation and chronic lung disease. Pediatrics 2009; 124:e439–e449.
85.
Johnson T, Patel A, Jegier B, Engstrom J, Meier P: The cost of morbidities in very low birth weight infants. J Pediatr 2013; 162: 243–249.e241.
86.
Miller V, Rice J, DeVoe M, Fos P: An analysis of program and family costs of case managed care for technology-dependent infants with bronchopulmonary dysplasia. J Pediatr Nurs 1998; 13: 244–251.
87.
Stone C Jr, Qiu Y, Kurland I, Slaughter J, Moore P, Cook-Mills J, Hartert T, Aschner J: Effect of maternal smoking on plasma and urinary measures of vitamin E isoforms in the first month after extreme preterm birth. J Pediatr 2018, Epub ahead of print.
88.
Cook-Mills J, Gebretsadik T, Abdala-Valencia H, Green J, Larkin E, Dupont W, Shu X, Gross M, Bai C, Gao Y, Hartman T, Rosas-Salazar C, Hartert T: Interaction of vitamin E isoforms on asthma and allergic airway disease. Thorax 2016; 71: 954–956.
89.
McEvoy C, Schilling D, Clay N, Jackson K, Go M, Spitale P, Bunten C, Leiva M, Gonzales D, Hollister-Smith J, Durand M, Frei B, Buist A, Peters D, Morris C, Spindel E: Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA 2014; 311: 2074–2082.
90.
Ortega R, López-Sobaler A, Martinez R, Andrés P, Quintas M: Influence of smoking on vitamin E status during the third trimester of pregnancy and on breast-concentrations in Spanish women. Am J Clin Nutr 1998; 68: 662–667.
91.
Acuff R, Dunworth R, Webb L, Lane J: Transport of deuterium-labeled tocopherols during pregnancy. Am J Clin Nutr 1998; 67: 459–464.
92.
Debier C, Larondelle Y: Vitamins A and E: metabolism, roles and transfer to offspring. Br J Nutr 2005; 93: 153–174.
93.
Betancor-Fernandez A, Sies H, Stahl W, Polidori M: In vitro antioxidant activity of 2,5,7,8-tetramethyl-2-(2-carboxyethyl)-6- hydroxychroman (alpha-CEHC), a vitamin E metabolite. Free Radic Res 2002; 36: 915–921.
94.
Uto-Kondo H, Kiyose C, Ohmori R, Saito H, Taguchi C, Kishimoto Y, Machida N, Hasegawa M, Yoshioka E, Saita E, Hirata Y, Igarashi O, Kondo K: The coantioxidative effects of carboxyethyl-6-hydroxychromans and α-tocopherol. J Nutri Sci Vitaminol (Tokyo) 2007; 53: 301–305.
95.
Contin D, Munne-Bosch S: Interspecific variation in vitamin E levels and the extent of lipid peroxidation in pioneer and non-pioneer species used in tropical forest restoration. Tree Physiol 2016; 36: 1151–1161.
96.
Meydani S, Barklund M, Liu S, Meydani M, MIller R, Cannon J, Morrow F, Rocklin R, Blumberg J: Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52: 557–563.
97.
Hsieh C, Huang C, Lin B: Low and high levels of α-tocopherol exert opposite effects on IL-2 possibly through the modulation of PPAR-γ, IκBα, and apoptotic pathway in activated splenocytes. Nutrition 2006; 22: 433–440.
98.
Jiang Q, Ames B: γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J 2003; 17: 816–822.
99.
Jiang Q, Elson-Schwab I, Courtemanche C, Ames B: Gamma tocopherol and its major metabolite, in contrast to alpha tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 2000; 97: 11494–11499.
100.
Wu D, Meydani M, Beharka A, Serafini M, Martin K, Meydani S: In vitro supplementation with different tocopherol homologues can affect the function of immune cells in old mice. Free Radic Biol Med 2000; 28: 643–651.
101.
Boscoboinik D, Chatelin E, Bartoli G, Azzi A: Molecular basis of alpha-tocopherol inhibition of smooth muscle proliferation in vitro. EXS 1992; 62: 164–177.
102.
Kempna P, Reiter E, Arock M, Azzi A, Zingg J: Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J Biol Chem 2004; 279: 50700–50709.
103.
Gerondakis S, Siebenlist U: Roles of the NF-κB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol 2010; 2:a000182.
104.
Oh H, Ghosh S: NF-kB: roles and regulation in different CD4+ T-cell subsets. Immunol Rev 2013; 252: 41–51.
105.
Devaraj S, Jialal I: Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of α-tocopherol supplementation. Circulation 2000; 102: 191–196.
106.
Devaraj S, Li D, Jialal I: The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 1996; 98: 756–763.
107.
Abdala-Valencia H, Berdnikovs S, Soveg F, Cook-Mills J: α-Tocopherol supplementation of allergic female mice inhibits development of CD11c+CD11b+ dendritic cells in utero and allergic inflammation in neonates. Am J Physiol Lung Cell Mol Physiol 2014; 307:L482–L496.
108.
Abdala-Valencia H, Soveg F, Cook-Mills J: γ-Tocopherol supplementation of allergic female mice augments development of CD11c+CD11b+ dendritic cells in utero and allergic inflammation in neonates. Am J Physiol Lung Cell Mol Physiol 2016; 310: L759–L771.
109.
Puklin J, Simon R, Ehrenkranz R: Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome. Opthalmology 1982; 89: 96–103.
110.
Al-Sonboli N, Al-Aghbari N, Al-Aryani A, Atef Z, Brabin B, Shenkin A, Roberts E, Harper G, Hart C, Cuevas L: Micronutrient concentrations in respiratory syncytial virus and human metapneumovirus in Yemeni children. Ann Trop Paediatr 2009; 29: 35–40.
111.
Galabov A, Mileva M, Simeonova L, Gegova G: Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice. Antivir Chem Chemother 2015; 24: 83–91.
112.
Sheridan P, Beck M: The immune response to herpes simplex virus encephalitis in mice is modulated by dietary vitamin E. J Nutr 2008; 138: 130–137.
113.
Sheridan P, Beck M: The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E. Free Radic Biol Med 2009; 46: 1581–1588.
114.
Beck M, Williams-Toone D, Levander O: Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency. Free Radic Biol Med 2003; 34: 1263–1270.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.